Clinical safety and efficacy of NG440: a novel combination of rho iso-alpha acids from hops, rosemary, and oleanolic acid for inflammatory conditions

Author： Minich Deanna M.   Bland Jeffrey S.   Katke Jeffrey   Darland Gary   Hall Amy   Lerman Robert H.   Lamb Joseph   Carroll Brian   Tripp Matthew  

Publisher： NRC Research Press

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.85, Iss.9, 2007-09, pp. : 872-883

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Safety of Rosuvastatin 5 mg in Combination with Fenofibric Acid 135 mg in Patients with Mixed Dyslipidemia – A Phase 3 Study

By Roth Eli   Rosenson Robert   Carlson Dawn   Fukumoto Sandra   Setze Carolyn   Blasetto James   Khurmi Nardev   Stolzenbach James   Williams Laura  

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 5-6, 2010-12 ,pp. : 421-428

Springer Publishing Company

Access to resources Recommend Favorite

One-Year Efficacy and Safety of Rosuvastatin + Fenofibric Acid Combination Therapy in Patients with Mixed Dyslipidemia: Evaluation of Dose Response

By Ferdinand Keith C.  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 2, 2012-04 ,pp. : 117-125

Adis International

Access to resources Recommend Favorite

Antidiabetic potential of oleanolic acid from Ligustrum lucidum Ait.

By Gao Dawei   Li Qingwang   Li Ying   Liu Zhihua   Liu Zhiwei   Fan Yusheng   Han Zengsheng   Li Jian   Li Kun  

Canadian Journal of Physiology and Pharmacology, Vol. 85, Iss. 11, 2007-11 ,pp. : 1076-1083

NRC Research Press

Access to resources Recommend Favorite

Rosuvastatin: efficacy, safety and clinical effectiveness

By Soran Handrean   Durrington Paul  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 12, 2008-08 ,pp. : 2145-2160

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Safety of Rosuvastatin and Fenofibric Acid Combination Therapy versus Simvastatin Monotherapy in Patients with Hypercholesterolemia and Hypertriglyceridemia: A Randomized, Double-Blind Study

By Roth Eli M.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 3, 2010-06 ,pp. : 175-186

Adis International

Access to resources Recommend Favorite